First-Line and Second-Line Seizure Drug Dosing
For first-line treatment of seizures, use lorazepam 0.1 mg/kg IV (maximum 4 mg per dose) or midazolam 0.2 mg/kg IM (maximum 10 mg), and if seizures persist after optimal benzodiazepine dosing, immediately administer a second-line agent: fosphenytoin 20 PE/kg IV, levetiracetam 60 mg/kg IV (maximum 4500 mg), or valproate 40 mg/kg IV—all three have equivalent efficacy.
First-Line Benzodiazepine Dosing
The evidence consistently supports benzodiazepines as first-line therapy across all guidelines 1, 2. However, underdosing remains a critical problem—recent data shows only 17% of patients receive adequate initial benzodiazepine doses 3, and inadequate total benzodiazepine dosing is significantly associated with increased mortality 3.
Specific Benzodiazepine Regimens:
Lorazepam (preferred when IV access available): 0.1 mg/kg IV over 2-3 minutes (maximum 4 mg per dose); may repeat once after 5-10 minutes 1, 2
Midazolam (preferred when no IV access):
Diazepam (less preferred due to shorter duration):
Critical pitfall: The pediatric guidelines note that lorazepam has prolonged anticonvulsant activity compared to diazepam, which redistributes rapidly and often requires a long-acting agent within 15-20 minutes 1. A second dose of benzodiazepine should be given at the 5-minute mark if seizures continue 4.
Second-Line Antiepileptic Drug Dosing
The 2024 ACEP guideline provides Level A evidence that fosphenytoin, levetiracetam, and valproate have similar efficacy as second-line agents 2. This is based on the landmark ESETT trial showing no superiority among these three options 2.
Specific Second-Line Regimens:
Fosphenytoin (preferred over phenytoin): 20 PE/kg IV at maximum rate of 150 PE/min 5, 2
- Advantages: Faster administration, fewer soft tissue complications than phenytoin
- Adverse effects: Hypotension, cardiac dysrhythmias 5
Levetiracetam: 60 mg/kg IV (maximum 4500 mg) at 100 mg/min 5, 2
Valproate: 40 mg/kg IV at 40 mg/min (some sources cite 20-30 mg/kg) 5
The 2014 guideline evidence shows valproate was more effective than phenytoin as second-line therapy (79% vs 25% seizure control) 5, though the 2024 ACEP guideline found all three agents equivalent 2.
Refractory Status Epilepticus (Third-Line)
For seizures continuing despite benzodiazepines and second-line agents:
Midazolam continuous infusion: Loading dose 0.15-0.2 mg/kg, then 1 mg/kg/min, increasing by 1 mg/kg/min every 15 minutes (maximum 5 mg/kg/min) 1
Propofol: 2 mg/kg bolus, may repeat in 3-5 minutes; maintenance 5 mg/kg/hour 5
Phenobarbital: 10-20 mg/kg; may repeat 5-10 mg/kg at 10 minutes 5
- Efficacy 58-90% but significant hypotension and respiratory depression 5
Critical Clinical Considerations
Timing is everything: The 2024 systematic review emphasizes that seizures of longer duration become self-sustaining and harder to break 4. Status epilepticus occurs in 22% of ED seizure cases, and up to 40% will be benzodiazepine-refractory 4.
Weight-based dosing matters: For phenytoin, patients receiving 1000 mg fixed dose were less likely to reach therapeutic levels compared to weight-based ≥15 mg/kg dosing (29% vs 60%) 6. Maintenance dosing of at least 400 mg/day or >5 mg/kg/day is recommended 6.
Respiratory monitoring is mandatory: All benzodiazepines increase apnea risk, especially when combined with other sedatives 1. Prepare for respiratory support and have flumazenil available, though note it will reverse anticonvulsant effects 1.
Avoid common errors: Do not prescribe benzodiazepines or antiseizure medications for functional seizures without co-occurring epilepsy 7. The 2026 AAN guideline specifically recommends against this practice and advises tapering these medications in such patients 7.